Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Frontiers in Oncology
|
November 30, 2020
Linking Immunoevasion and Metabolic Reprogramming in B-Cell-Derived Lymphomas
Martin Böttcher, Rebecca Baur, Andrej Stoll, et al.
Blood
|
October 30, 2010
Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress
Dimitrios Mougiakakos, C Christian Johansson, Regina Jitschin, et al.
Oncotarget
|
March 24, 2018
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner
Romy Loschinski, Martin Böttcher, Andrej Stoll, et al.
Biomolecules
|
September 23, 2022
Lipotoxicity as a Barrier for T Cell-Based Therapies
Romy Böttcher-Loschinski, Judit Rial Saborido, Martin Böttcher, et al.
Haematologica
|
February 23, 2019
Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity
Junyan Lu, Martin Böttcher, Tatjana Walther, et al.
Scientific Reports
|
July 6, 2022
The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome
Silja Richter, Martin Böttcher, Simon Völkl, et al.
American Journal of Physiology. Cell Physiology
|
February 13, 2025
Metabolic T-cell phenotypes: from bioenergetics to function
Nouria Jantz-Naeem, Nese Guvencli, Romy Böttcher-Loschinski, et al.
Blood Advances
|
August 9, 2020
Exploitable metabolic dependencies in MLL-ENL-induced leukemia
Maria-Paz Garcia-Cuellar, Jennifer Lawlor, Martin Böttcher, et al.
Frontiers in Oncology
|
March 6, 2023
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
Nouria Jantz-Naeem, Romy Böttcher-Loschinski, Katrin Borucki, et al.
Cancer Immunology, Immunotherapy : CII
|
January 5, 2023
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib
Lukas Häselbarth, Axel Karow, Kristin Mentz, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Frontiers in Oncology
|
November 30, 2020
Linking Immunoevasion and Metabolic Reprogramming in B-Cell-Derived Lymphomas
Martin Böttcher, Rebecca Baur, Andrej Stoll, et al.
Blood
|
October 30, 2010
Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress
Dimitrios Mougiakakos, C Christian Johansson, Regina Jitschin, et al.
Oncotarget
|
March 24, 2018
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner
Romy Loschinski, Martin Böttcher, Andrej Stoll, et al.
Biomolecules
|
September 23, 2022
Lipotoxicity as a Barrier for T Cell-Based Therapies
Romy Böttcher-Loschinski, Judit Rial Saborido, Martin Böttcher, et al.
Haematologica
|
February 23, 2019
Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity
Junyan Lu, Martin Böttcher, Tatjana Walther, et al.
Scientific Reports
|
July 6, 2022
The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome
Silja Richter, Martin Böttcher, Simon Völkl, et al.
American Journal of Physiology. Cell Physiology
|
February 13, 2025
Metabolic T-cell phenotypes: from bioenergetics to function
Nouria Jantz-Naeem, Nese Guvencli, Romy Böttcher-Loschinski, et al.
Blood Advances
|
August 9, 2020
Exploitable metabolic dependencies in MLL-ENL-induced leukemia
Maria-Paz Garcia-Cuellar, Jennifer Lawlor, Martin Böttcher, et al.
Frontiers in Oncology
|
March 6, 2023
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
Nouria Jantz-Naeem, Romy Böttcher-Loschinski, Katrin Borucki, et al.
Cancer Immunology, Immunotherapy : CII
|
January 5, 2023
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib
Lukas Häselbarth, Axel Karow, Kristin Mentz, et al.
Page
of 6